Research on the selection criteria and implementation path of "dual channel" management mechanism for national reimbursement negotiation drugs

HAN Xiaorui, DING Jinxi, LI Wei, CHEN Ye

PDF(2214 KB)
主办：上海医药工业研究院
　　　中国药学会
ISSN 1672-9188   CN 31-1939/R   SLYHAA
World Clinical Drug
PDF(2214 KB)
World Clinical Drug ›› 2021, Vol. 42 ›› Issue (09) : 717-724. DOI: 10.13683/j.wph.2021.09.002
Topic

Research on the selection criteria and implementation path of "dual channel" management mechanism for national reimbursement negotiation drugs

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2021, 42(09): 717-724 https://doi.org/10.13683/j.wph.2021.09.002

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(2214 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉